Search papers, labs, and topics across Lattice.
This study employs a Contextual Markov Decision Process (CMDP) model to optimize follow-up intervals for Type 2 Diabetes (T2D) patients by analyzing Electronic Health Record (EHR) data from over 22,000 patients. By identifying distinct patient contexts through dimensionality reduction and clustering, the model recommends tailored follow-up schedules that significantly reduce expected cumulative costs compared to traditional fixed interval guidelines. The CMDP policies suggest follow-up intervals ranging from 1 month to 12 months based on individual risk profiles, achieving cost reductions of up to 34.8% in high-comorbidity contexts.
Tailoring follow-up intervals for Type 2 Diabetes patients can cut costs by over 34% while enhancing care based on individual risk profiles.
Chronic disease management relies on regular patient-provider interactions to follow-up on disease progression and control. For Type 2 Diabetes (T2D), current guidelines prescribe fixed time intervals between subsequent primary care visits for all patients, overlooking heterogeneity in clinical trajectories and patient characteristics. This study introduces a Contextual Markov Decision Process (CMDP) model to optimize subpopulation-specific follow-up interval decisions using Electronic Health Record (EHR) data from 22,154 T2D patients across 10 primary care clinics. Contexts are identified by: i) dimensionality reduction of variables representing the individual health trajectories utilizing Principal Component Analysis, and ii) assigning patients to contexts via principal components and additional patient-level features using clustering. Two distinct contexts emerged, representing a lower- and a higher-risk subpopulation. CMDP-derived policies recommend: (i) follow-up within 1 month if lab value at current visit is unmeasured; (ii) up to 3 months for elevated lab values or recent hospitalizations; and (iii) 6 to 12 months for sustained glycemic control, with shorter follow-up intervals for patients in high-risk context. The optimal policies achieved lower expected cumulative cost than benchmarks (e.g., in the higher-comorbidity context, the CMDP policy reduced cost by about 34.8%, and in the lower-comorbidity context by about 6.4%, relative to an American Diabetes Association-like fixed interval follow-up policy. These findings demonstrate how context-aware approaches can inform adaptive follow-up strategies, and have the potential to advance chronic care management in primary care by synthesizing machine learning and probabilistic decision models.
